Japan Contract Development Manufacturing Organization Market Report 2024-2030, Featuring Lonza, Recipharm, LabCorp, Catalent, WuXi AppTec, CordenPharma, Cambrex, Bushu Pharmaceuticals and Nipro
21 juin 2024 04h50 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Japan Contract Development Manufacturing Organization Market Size, Share & Trends Analysis Report by Product Type (API, Drug Product), Workflow...
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
03 juin 2024 09h00 HE
|
Longeveron
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
28 mai 2024 07h00 HE
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
Key Growth Opportunities in the Oral Solid Dosage Formulation Industry - Fixed Dose Combination Products for Chronic Diseases, Medical Cannabidiol and Phase-appropriate Services for Orphan Drugs
27 mai 2024 04h35 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Oral Solid Dosage Formulation Industry" report has been added to ResearchAndMarkets.com's offering. This analysis...
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
23 mai 2024 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering
22 mai 2024 08h16 HE
|
BioConnection
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering Strategic partnership provides a...
$19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F
14 mai 2024 10h31 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Large Molecule Drug Substance CDMO Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials
14 mai 2024 09h31 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type,...
New Drug Approvals and Their Contract Manufacture 2024 Report - NDA Drug and Vaccine Approvals and the Levels of Outsourcing Associated with NDA Sub Segments
13 mai 2024 07h57 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "New Drug Approvals and Their Contract Manufacture - 2024 Edition" report has been added to ResearchAndMarkets.com's offering.This report is the 14th...
Avid Bioservices to Participate at Upcoming Investor Conferences
07 mai 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...